We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WGS icon
4476
GeneDx Holdings
WGS
$2.32B
$11K ﹤0.01%
370
-729
-66% -$33.4K
OMCC
4477
DELISTED
Old Market Capital Corp
OMCC
$11K ﹤0.01%
1,856
+1,418
+324% +$12.1K
SBT
4478
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$11K ﹤0.01%
1,794
-15,522
-90% -$92.2K
FRLA
4479
DELISTED
Fortune Rise Acquisition Corporation Class A Common Stock
FRLA
$11K ﹤0.01%
1,103
+281
+34% +$2.85K
DXYN
4480
DELISTED
Dixie Group Inc
DXYN
$11K ﹤0.01%
10,399
+6,491
+166% +$8.66K
ALLG
4481
DELISTED
Allego N.V.
ALLG
$11K ﹤0.01%
2,626
-7,016
-73% -$31.1K
CATC
4482
DELISTED
CAMBRIDGE BANCORP
CATC
$11K ﹤0.01%
141
-260
-65% -$21.4K
TCON
4483
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$11K ﹤0.01%
342
+261
+322% +$9.96K
OMIC
4484
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$11K ﹤0.01%
151
-3
-2% -$313
MRNS
4485
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$11K ﹤0.01%
1,615
-798
-33% -$4.91K
CYT
4486
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$11K ﹤0.01%
5,859
-141
-2% -$368
BPTH
4487
DELISTED
Bio-Path Holdings Inc
BPTH
$11K ﹤0.01%
169
+112
+196% +$8.51K
COMS
4488
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$11K ﹤0.01%
1,374
+1,221
+798% +$16.4K
GPP
4489
DELISTED
Green Plains Partners LP
GPP
$11K ﹤0.01%
+900
New +$11.7K
NMRD
4490
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$11K ﹤0.01%
5,249
+4,272
+437% +$8.54K
OHAA
4491
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
$11K ﹤0.01%
1,060
+901
+567% +$8.91K
APGB
4492
DELISTED
Apollo Strategic Growth Capital II
APGB
$11K ﹤0.01%
1,083
+380
+54% +$3.74K
AEY
4493
DELISTED
ADDvantage Technologies Group
AEY
$11K ﹤0.01%
624
-73
-10% -$1.23K
CPTN
4494
DELISTED
Cepton, Inc. Common Stock
CPTN
$11K ﹤0.01%
582
+479
+465% +$7.79K
EVLO
4495
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$11K ﹤0.01%
264
-34
-11% -$1.55K
DGNU
4496
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
$11K ﹤0.01%
1,121
– –
SIOX
4497
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$11K ﹤0.01%
38,306
+3,292
+9% +$1.13K
SPNE
4498
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$11K ﹤0.01%
1,921
-5,442
-74% -$34.6K
MDH
4499
DELISTED
MDH Acquisition Corp.
MDH
$11K ﹤0.01%
1,065
-46
-4% -$453
RBCN
4500
DELISTED
Rubicon Technology, Inc.
RBCN
$11K ﹤0.01%
5,237
+4,712
+898% +$50.9K
178 179
180
181 182

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.